AU1807188A - Human monoclonal antibodies binding determinants of gram negative bacteria - Google Patents
Human monoclonal antibodies binding determinants of gram negative bacteriaInfo
- Publication number
- AU1807188A AU1807188A AU18071/88A AU1807188A AU1807188A AU 1807188 A AU1807188 A AU 1807188A AU 18071/88 A AU18071/88 A AU 18071/88A AU 1807188 A AU1807188 A AU 1807188A AU 1807188 A AU1807188 A AU 1807188A
- Authority
- AU
- Australia
- Prior art keywords
- monoclonal antibodies
- human monoclonal
- negative bacteria
- gram negative
- antibodies binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1009—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/21—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pseudomonadaceae (F)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/24—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- G01N2333/255—Salmonella (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- G01N2400/50—Lipopolysaccharides; LPS
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Optics & Photonics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3677687A | 1987-04-10 | 1987-04-10 | |
US036776 | 1998-03-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1807188A true AU1807188A (en) | 1988-11-04 |
Family
ID=21890590
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU18071/88A Abandoned AU1807188A (en) | 1987-04-10 | 1988-04-01 | Human monoclonal antibodies binding determinants of gram negative bacteria |
Country Status (5)
Country | Link |
---|---|
KR (1) | KR890700832A (en) |
AU (1) | AU1807188A (en) |
IL (1) | IL85974A0 (en) |
WO (1) | WO1988008135A1 (en) |
ZA (1) | ZA882456B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2218703B (en) * | 1988-05-10 | 1992-10-28 | Sumitomo Chemical Co | Human monoclonal antibody to p.aeruginosa: its production and use |
EP3757130A1 (en) | 2013-09-26 | 2020-12-30 | Costim Pharmaceuticals Inc. | Methods for treating hematologic cancers |
JOP20200094A1 (en) | 2014-01-24 | 2017-06-16 | Dana Farber Cancer Inst Inc | Antibody molecules to pd-1 and uses thereof |
JOP20200096A1 (en) | 2014-01-31 | 2017-06-16 | Children’S Medical Center Corp | Antibody molecules to tim-3 and uses thereof |
JP6681905B2 (en) | 2014-09-13 | 2020-04-15 | ノバルティス アーゲー | ALK inhibitor combination therapy |
US11168131B2 (en) | 2015-11-10 | 2021-11-09 | Visterra, Inc. | Antibody molecule-drug conjugates and uses thereof |
KR102697723B1 (en) | 2017-01-18 | 2024-08-21 | 비스테라, 인크. | Antibody molecule-drug conjugates and uses thereof |
WO2021203024A1 (en) | 2020-04-03 | 2021-10-07 | Visterra, Inc. | Antibody molecule-drug conjugates and uses thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4834975A (en) * | 1984-05-25 | 1989-05-30 | Genetics Corporation | Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production |
US4918163A (en) * | 1985-09-27 | 1990-04-17 | Pfizer Inc. | Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria |
-
1988
- 1988-04-01 AU AU18071/88A patent/AU1807188A/en not_active Abandoned
- 1988-04-01 WO PCT/US1988/001047 patent/WO1988008135A1/en unknown
- 1988-04-04 IL IL85974A patent/IL85974A0/en unknown
- 1988-04-08 ZA ZA882456A patent/ZA882456B/en unknown
- 1988-12-10 KR KR1019880701642A patent/KR890700832A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL85974A0 (en) | 1988-09-30 |
KR890700832A (en) | 1989-04-27 |
WO1988008135A1 (en) | 1988-10-20 |
ZA882456B (en) | 1988-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6323686A (en) | Monoclonal antibodies binding determinants of gram negative bacteria | |
AU1480388A (en) | Altered antibodies | |
AU2782789A (en) | Monoclonal antibodies against human interleukin-4 and hybridomas producing the same | |
AU550364B2 (en) | Immunogen of lidocaine-protein conjugate and antibodies derived therefrom | |
AU1807188A (en) | Human monoclonal antibodies binding determinants of gram negative bacteria | |
AU2493184A (en) | Specific cea-family antigens, antibodies specific thereto and their methods of use | |
AU6036690A (en) | Human monoclonal antibodies to hiv-1mn gp 120 | |
ZA867342B (en) | Monoclonal antibodies binding determinants of grams negative bacteria | |
EP0285511A3 (en) | Monoclonal antibodies and their uses | |
EP0310413A3 (en) | Immobilized antibodies | |
AU2383288A (en) | Human anti-rh(d) monoclonal antibodies | |
GB2212500B (en) | Immobilized antibodies | |
AU2111088A (en) | Carrier of antigen or antibody | |
GB8722019D0 (en) | Human anti-rh(d)monoclonal antibodies | |
AU7649187A (en) | Preparation of monoclonal antibodies | |
AU2644088A (en) | Urease antigen product & process | |
AU5675790A (en) | Human monoclonal antibodies to sero-specific determinants of gram-negative bacteria | |
IL86960A0 (en) | Preparation of human monoclonal antibodies | |
AU2521288A (en) | Human anti-rh(d) monoclonal antibodies | |
GB2214509B (en) | Human monoclonal antibody to p.aeruginosa and gram negative bacteria: its production and use | |
AU618720B2 (en) | Monoclonal antibodies | |
AU8864791A (en) | Antibodies and methods for diagnosis and treatment of diabetes | |
ZW9888A1 (en) | Monoclonal antibodies and methods for diagnosis of pytophthora infection | |
AU2389588A (en) | Human anti-rh(d) monoclonal antibodies | |
AU5217890A (en) | Monoclonal antibodies in vaccine formulations |